当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 现金流量表

药明康德

(603259)

  

流通市值:3858.07亿  总市值:4675.63亿
流通股本:24.73亿   总股本:29.97亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金28,213,614,195.4212,564,206,385.749,091,382,140.1834,327,532,724.92
  收到的税费返还902,942,139.84529,798,491.221,634,093,531.381,093,800,903.48
  收到其他与经营活动有关的现金720,061,192.06466,971,301.731,027,087,659.72690,144,986.47
  经营活动现金流入小计29,836,617,527.3213,560,976,178.6551,752,563,331.2836,111,478,614.87
  购买商品、接受劳务支付的现金10,759,486,083.124,801,463,683.818,403,824,521.7913,228,850,010.16
  支付给职工以及为职工支付的现金5,954,553,189.463,549,166,099.9210,450,935,927.567,928,078,759.92
  支付的各项税费2,522,179,774.481,217,418,205.333,755,189,879.642,160,136,328.87
  支付其他与经营活动有关的现金901,256,092.18397,117,863.071,939,451,380.291,381,578,848.45
  经营活动现金流出小计20,137,475,139.249,965,165,852.1234,549,401,709.2824,698,643,947.4
  经营活动产生的现金流量净额9,699,142,388.083,595,810,326.5317,203,161,62211,412,834,667.47
二、投资活动产生的现金流量:
  收回投资收到的现金13,176,532,991.123,366,510,544.5121,007,291,673.4811,163,983,140.14
  取得投资收益收到的现金118,181,688.8129,116,209.77482,697,536.68237,240,096.62
  处置固定资产、无形资产和其他长期资产收回的现金净额115,771,107.0424,688,122.375,118,927.49,761,249.99
  处置子公司及其他营业单位收到的现金净额398,053,880.94398,053,880.942,902,727,868.21,343,881,409.16
  投资活动现金流入小计13,808,539,667.913,818,368,757.5224,467,836,005.7612,754,865,895.91
  购建固定资产、无形资产和其他长期资产支付的现金2,961,579,116.411,194,798,903.265,538,150,829.943,566,317,746.46
  投资支付的现金21,703,449,839.137,971,938,663.5520,874,795,084.78,783,584,477.76
  投资活动现金流出小计24,665,028,955.549,166,737,566.8126,412,945,914.6412,349,902,224.22
  投资活动产生的现金流量净额-10,856,489,287.63-5,348,368,809.29-1,945,109,908.88404,963,671.69
三、筹资活动产生的现金流量:
  吸收投资收到的现金--7,045,823,546.016,995,823,546.01
  取得借款收到的现金5,770,910,166.773,377,302,944.5114,091,218,928.8111,575,750,138.88
  发行债券收到的现金6,944,451,728.64---
  筹资活动现金流入小计12,715,361,895.413,377,302,944.5121,137,042,474.8218,571,573,684.89
  偿还债务支付的现金5,620,300,0003,400,300,00010,528,620,797.528,718,797,498.61
  分配股利、利润或偿付利息支付的现金4,753,541,066.1516,953,610.044,992,100,926.544,966,801,138.59
  其中:子公司支付给少数股东的股利、利润--23,518,29023,518,290
  支付其他与筹资活动有关的现金3,240,831,304.1735,028,816.844,492,779,705.34,463,317,745.01
  筹资活动现金流出小计13,614,672,370.323,452,282,426.8820,013,501,429.3618,148,916,382.21
  筹资活动产生的现金流量净额-899,310,474.91-74,979,482.371,123,541,045.46422,657,302.68
四、汇率变动对现金及现金等价物的影响-445,588,979.92-198,774,624.87-370,473,427.27-209,209,966.1
五、现金及现金等价物净增加额-2,502,246,354.38-2,026,312,59016,011,119,331.3112,031,245,675.74
  加:期初现金及现金等价物余额29,455,830,548.9529,455,830,548.9513,444,711,217.6413,444,711,217.64
  期末现金及现金等价物余额26,953,584,194.5727,429,517,958.9529,455,830,548.9525,475,956,893.38
补充资料:
  净利润11,126,333,943.9-19,333,065,892.26-
  资产减值准备68,368,895.87-541,555,966.37-
  固定资产和投资性房地产折旧1,758,977,935.91-3,164,557,339.38-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,758,977,935.91-3,164,557,339.38-
  无形资产摊销58,368,193.16-132,413,984.1-
  长期待摊费用摊销33,668,132.76-89,610,245.16-
  处置固定资产、无形资产和其他长期资产的损失914,869.48-58,067,020.13-
  固定资产报废损失1,843,753.65-7,094,067.73-
  公允价值变动损失-684,234,468.06-137,097,911.32-
  财务费用548,528,885.02-1,073,373,133.94-
  投资损失-227,724,271.36--8,588,017,064.9-
  递延所得税-69,828,026.03--197,904,753.64-
  其中:递延所得税资产减少-96,518,413.82--115,912,084.53-
    递延所得税负债增加26,690,387.79--81,992,669.11-
  存货的减少-2,127,689,190.2--3,662,118,123.51-
  经营性应收项目的减少-3,709,917,660.34--229,618,572.96-
  经营性应付项目的增加2,405,644,708.86-3,797,761,790.71-
  其他341,582,115.04-801,757,310.91-
  现金的期末余额26,953,584,194.57-29,455,830,548.95-
  减:现金的期初余额29,455,830,548.95-13,444,711,217.64-
  现金及现金等价物的净增加额-2,502,246,354.38-16,011,119,331.31-
公告日期2026-08-042026-04-282026-03-242025-10-27
审计意见(境内)标准无保留意见
TOP↑